BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 17600908)

  • 1. Treatment of Kawasaki disease.
    Taddio A; Rosé CD
    N Engl J Med; 2007 Jun; 356(26):2747; author reply 2748. PubMed ID: 17600908
    [No Abstract]   [Full Text] [Related]  

  • 2. Adverse effects of methylprednisolone pulse therapy in refractory Kawasaki disease.
    Miura M; Ohki H; Yoshiba S; Ueda H; Sugaya A; Satoh M; Yamagishi H
    Arch Dis Child; 2005 Oct; 90(10):1096-7. PubMed ID: 16177169
    [No Abstract]   [Full Text] [Related]  

  • 3. Revisiting steroids in the primary treatment of acute Kawasaki disease.
    Burns JC
    J Pediatr; 2006 Sep; 149(3):291-2. PubMed ID: 16939734
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of steroid pulse therapy on immunoglobulin-resistant Kawasaki disease.
    Furukawa T; Kishiro M; Akimoto K; Nagata S; Shimizu T; Yamashiro Y
    Arch Dis Child; 2008 Feb; 93(2):142-6. PubMed ID: 17962370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized trial of pulsed corticosteroid therapy for primary treatment of Kawasaki disease.
    Newburger JW; Sleeper LA; McCrindle BW; Minich LL; Gersony W; Vetter VL; Atz AM; Li JS; Takahashi M; Baker AL; Colan SD; Mitchell PD; Klein GL; Sundel RP;
    N Engl J Med; 2007 Feb; 356(7):663-75. PubMed ID: 17301297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is there a role for corticosteroids in Kawasaki disease?
    Shulman ST
    J Pediatr; 2003 Jun; 142(6):601-3. PubMed ID: 12838185
    [No Abstract]   [Full Text] [Related]  

  • 7. [Methylprednisolone pulse therapy in Kawasaki disease].
    Miura M; Matsuoka M; Kohno K; Ohki H; Yoshiba S
    Nihon Rinsho; 2008 Feb; 66(2):338-42. PubMed ID: 18265457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Reply to questions regarding diagnosis and treatment of Kawasaki disease].
    Wang HW
    Zhonghua Er Ke Za Zhi; 2006 May; 44(5):337-8. PubMed ID: 16780708
    [No Abstract]   [Full Text] [Related]  

  • 9. Current recommendations for the pharmacologic therapy in Kawasaki syndrome and management of its cardiovascular complications.
    De Rosa G; Pardeo M; Rigante D
    Eur Rev Med Pharmacol Sci; 2007; 11(5):301-8. PubMed ID: 18074939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corticosteroid pulse combination therapy for refractory Kawasaki disease: a randomized trial.
    Ogata S; Ogihara Y; Honda T; Kon S; Akiyama K; Ishii M
    Pediatrics; 2012 Jan; 129(1):e17-23. PubMed ID: 22144699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunoglobulin in suspected Kawasaki disease].
    García Soblechero E; Gómez Santos E; Domínguez Quintero ML; González Vila L
    An Pediatr (Barc); 2010 Sep; 73(3):151-2. PubMed ID: 20605119
    [No Abstract]   [Full Text] [Related]  

  • 12. The strategy of immune globulin resistant Kawasaki disease: a comparative study of additional immune globulin and steroid pulse therapy.
    Ogata S; Bando Y; Kimura S; Ando H; Nakahata Y; Ogihara Y; Kaneko T; Minoura K; Kaida M; Yokota Y; Furukawa S; Ishii M
    J Cardiol; 2009 Feb; 53(1):15-9. PubMed ID: 19167633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulse methylprednisolone therapy in the treatment of immune globulin-resistant Kawasaki disease: case report and review of the literature.
    Hung JJ; Chiu CH
    Ann Trop Paediatr; 2004 Mar; 24(1):89-93. PubMed ID: 15005973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resistant Kawasaki disease.
    Nachiappan J; May M; Hawker RE; Hong P
    J Paediatr Child Health; 2004; 40(9-10):576-8. PubMed ID: 15367156
    [No Abstract]   [Full Text] [Related]  

  • 15. Primary treatment of incomplete Kawasaki disease with infliximab and methylprednisolone in a patient with a contraindication to intravenous immune globulin.
    Shirley DA; Stephens I
    Pediatr Infect Dis J; 2010 Oct; 29(10):978-9. PubMed ID: 20431427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Improving the diagnosis and therapy of Kawasaki disease].
    Du JB
    Zhonghua Er Ke Za Zhi; 2006 May; 44(5):321-3. PubMed ID: 16780704
    [No Abstract]   [Full Text] [Related]  

  • 17. [Intravenous immunoglobulin-resistant Kawasaki disease with hemophagocytosis].
    Servel AC; Vincenti M; Darras JP; Lalande M; Rodière M; Filleron A
    Arch Pediatr; 2012 Jul; 19(7):741-4. PubMed ID: 22652521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of corticosteroid therapy in refractory Kawasaki patients.
    Al-Mayouf SM
    Clin Rheumatol; 2004 Feb; 23(1):11-3. PubMed ID: 14749974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Risk stratification and prediction of resistance to intravenous immunoglobulin in Kawasaki disease].
    Kobayashi T; Inoue Y; Morikawa A
    Nihon Rinsho; 2008 Feb; 66(2):332-7. PubMed ID: 18260333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Advance in diagnosis and treatment of intravenous immunogolobulin-resistant Kawasaki disease].
    Zhang Q
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Apr; 11(4):318-21. PubMed ID: 19374823
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.